Stopping Muscle Scarring in Muscular Dystrophies
Understanding the Mechanisms of Fibrosis in Muscular Dystrophies
This project explores how muscle scarring, called fibrosis, develops in muscular dystrophies like Duchenne MD, hoping to find new ways to help muscles heal better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11092236 on NIH RePORTER |
What this research studies
Muscular dystrophies cause muscles to weaken and waste away, eventually being replaced by scar tissue and fat. This scarring prevents muscles from regenerating properly, which is a major challenge for patients. Our team is looking into specific cell processes that contribute to this scarring and prevent muscle repair. We are focusing on a particular target, NOX4, which has shown promise in reducing muscle scarring and improving muscle health in models of Duchenne MD. We believe NOX4 in certain cells might be preventing the body from clearing away scar-forming cells after muscle injury.
Who could benefit from this research
Good fit: This foundational research is relevant to patients with muscular dystrophies, particularly those with Duchenne MD, as it seeks to understand the underlying disease processes.
Not a fit: Patients without muscular dystrophies or related muscle wasting conditions would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that reduce muscle scarring and improve muscle regeneration for individuals living with muscular dystrophies.
How similar studies have performed: Previous work has shown that targeting NOX4 using genetic and pharmacological methods led to significant reductions in muscle fibrosis and improved muscle remodeling in severely dystrophic muscle models.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Hammers, David W — University of Florida
- Study coordinator: Hammers, David W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.